Recruitment of Subjects Best Practices

Similar documents
ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016

Recruitment of Research Participants

Tip Sheet 17: Review of Research by the Expedited Procedure

ROLE OF THE RESEARCH COORDINATOR Investigational New Drug Application-Sponsor Responsibilities 21CFR Part , subpart D

CHECKLIST: Pre-review

Pharmaceutical companies are turning to private practices to conduct clinical trials. An insider tells you what you need to know and what to avoid in

University of California, Irvine Human Research Protections Standard Operating Policies and Procedures

Learning about Clinical Trials

RECRUITING OF AND ADVERTISING FOR SUBJECTS

Investigational New Drug Development Steps for CRCs

Standard Operating Procedures Guidelines for Good Clinical Practice

MANUAL: Administrative Policy & Procedure Manual POLICY:

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

FRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up?

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.

Outline of Discussion

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Guidelines for Setting Up a Regulatory Binder

MCW Office of Research Standard Operating Procedure

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

Protocol Submission Form

FACTS YOU NEED TO KNOW UNITED STATES OF AMERICA

Lessons learned on the road to being a Sponsor- Investigator

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

A Patient/Advocate Perspective

Clinical trials patient-education brochure

You ve Got the POWER! What You Should Know About Clinical Trials

Volunteering for Clinical Trials

Objectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

Human Research Protection Program. Investigator Manual

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

Reporting Results and Incidental Findings to Research Participants

Selecting A Right Patient Recruitment Company: The Key To Success

The world contains a vast number of cultures with varying customs and traditions Multinational research is a global enterprise

IND Development Process Published on ResearchGo UCLA (

07/30/2013. Record of Revisions IRB Page 1 of 17

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Clinical Trials: What You Need to Know

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

Developing and Implementing Standard Operating Procedures

Recruitment and Participant Study Materials Guidelines

11.0 FDA-Regulated Research

About Clinical Trials

Quality Control in Clinical Trials Blinding, Clinical Event Committees, Core Labs, and Data Standards

PROTOCOL DRAFTING GUIDE

Expanded Access and the Individual Patient IND

June 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB

H-20 Page 1 of 5. Institutional Review Board Policy Manual HUMANITARIAN USE DEVICE (HUD) REQUIREMENTS

Regulatory Document Guidelines for DMID Clinical Studies. Version Oct-2005

Investigator Manual January 23, 2014

Participant Materials and Retention Program Guidelines

WCG ACADEMY COURSE OVERVIEW

Human Subjects Protection: Training for Research Teams

RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs. Greater Manchester Mental Health NHS Foundation Trust

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Talking to Active Investigators: Interview Findings

Understanding clinical research trials

Human Research Protection Program Policy

External IRB Review What Does it Mean for Your Institution

Responsibilities of Investigators for Clinical Trials from Consent to Safety Reporting

Streamlining IRB Procedures for Expanded Access

HOW TO IDENTIFY & PRIORITIZE TRIAL STAKEHOLDERS

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation

Conducted Under an IND to Support a

USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH

A LOOK AT WHAT S INSIDE

The Importance of Feasibility Studies for Oncology Clinical Trials

FDA Compliance Actions Against IRBs and Clinical Investigators

Regulatory Visits, Audits and Investigations

Unpacking Expanded Access to Investigational Drugs and Biologics

To document the review procedures for a submission regarding compassionate/treatment use of investigational drugs, biologics and devices.

About Clinical Trials: What They Can Mean For You?

SUBJECT: INSTITUTIONAL REVIEW BOARD (IRB) - HUMANITARIAN USE DEVICES

Expanded Access to Investigational Imaging Drugs

Analysis of the Department of Labor s PERM Rule Overhauling the Permanent Labor Certification Process

Clinical Research with Drugs/Biologics and Devices & Good Clinical Practices

Introduction to Clinical Research

HUMAN GENETICS INITIATIVE

Standard Operating Procedure

3. Human Biomedical Research. Defining Human Biomedical Research

MARKEY CANCER CENTER STANDARD OPERATING PROCEDURES. SOP No.: MCC Type: Final

ACCESSIBILITY FOR ONTARIANS WITH DISABILITIES ACT, INTEGRATED ACCESSIBILITY STANDARDS Multi Year Plan. Last updated: 15 May 2014

HEALTH CARE PROVIDER TOOLKIT

ESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL

Compassionate Use Navigator Information for Physicians

ACCESSIBILITY FOR ONTARIANS WITH DISABILITIES ACT, 2005 INTEGRATED ACCESSIBILITY STANDARDS Multi Year Plan mottlab Inc.

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR CLINICAL RESEARCH

MCW Office of Research Standard Operating Procedure

annex 3. Template consent form for biobanking

SWOG Subject: Requests for Patient Data Original Release Date: April 2006 Departments Affected: All Revision Date: May 2013

HIV and Recruitment. Advice for job ApplicAnts living with hiv

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah

RESEARCH ETHICS BOARD GUIDELINES SUBMISSION OF RESEARCH PROJECTS

Administrative Policies VMC #638.1 and Procedures Manual

1 The Clinical Research Coordinator (CRC)... 1

Advocate Health Care Network. Human Research Protection Program. Plan

Clinical Trial Basics:

Transcription:

UCLA CTSI WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS ROLE OF THE RESEARCH COORDINATOR Recruitment of Subjects Best Practices May 2016

Objectives Definitions Goals and Barriers Recruitment Guidance Ethical Concerns Acceptable Methods Who may recruit subjects Eligibility and Recruitment

Definition of Recruitment Most investigators believe, it is just this easy.

The Reality is that Recruitment Barriers Exist Examples Fear of receiving a placebo Misunderstanding of research design terminology Patient s reluctance to go against their primary doctor s recommendations Fear of being treated like a guinea pig Distance subject/patient would have to travel to participate What will it cost for the person to participate Family objections Investigator: Where are the subjects? Surveys of subjects have identified these common barriers to participation.

Understand the Positive Reasons Subjects DO Join a Clinical Trial Access to best care and doctors for their condition Belief they would benefit future patients Belief they would get more care and attention Belief/Hope that they will benefit Remember: The research team has an obligation to remain supportive while allowing independent decisionmaking by the subject.

Recruitment Goals How many participants need to be contacted to meet your enrollment goals? This applies to small or large studies, and particularly if you have stringent eligibility criteria..more on that later! 3%-20% OF POTENTIAL SUBJECTS WHO UNDERGO SCREENING, ARE FINALLY ENROLLED Particularly important to keep this in mind when considering the cost of recruitment in time and energy!

Recruitment Goals Tamoxifen vs. Raloxifene (STAR) breast cancer prevention trial Enrollment data two years from start: 96,244 women took risk assessment 54,890 were eligible 11,307 chose to participate (~12%) Minority Data (all races and ethnic backgrounds) 15,022 minority women took risk assessment 3,781 were eligible 636 chose to participate (~4%)

Definition of Recruitment Another definition of Recruitment experienced by research teams; budget, budget, budget! Recruitment is The desperate, frustrating, costly search for participants who obviously reside in some other place than where you are searching. And whose enrollment cost may become comparable to the national debt! $$$$$$$$$$$$$ $$$$$$$$ $$$$ $$ $

Recruitment Goals Implement recruitment strategy that meets UCLA IRB approval: Newspapers/radio are costly and need IRB approval Track recruitment efforts for sponsor and audit. Social-media strategies require expertise and IRB approval Local support group meetings provide a safe opportunity to ask questions and hear from other participants. Flyers need IRB approval & are good to reach many; protect privacy since the subject contacts you. Develop a script for phone recruitment that can be approved by the UCLA IRB. Any staff doing phone screening will have the same conversation with potential subjects. Tumor boards or clinical staff meetings work best with the use of a fast facts description of open studies with a partial eligibility criteria.

Recruitment Guidance! No matter the method, all recruitment documents MUST be submitted with the initial application for UCLA IRB review along with a description of your recruitment plans. If you modify the documents or the plan, it must return for re-approval! For additional recruitment guidance-see ResearchGo ResearchGO.ucla.edu/recruitmentstrategy

Ethical Concerns Recruitment Guidance All research staff must remember that Recruitment is a very important step in the management of a clinical trial. If you cannot recruit the number of subjects proposed for adequate analysis, the study was in vain. When recruiting, subjects are not yet on a clinical trial. How the research staff handles the act of approaching directly or indirectly the people who can be considered for a study, has its own set of guidelines from the UCLA IRB. The IRB will want to know your recruitment plans in the initial protocol submission, and if you later modify this plan.

Ethical Concerns Recruitment Guidance Careful respect for privacy of the individual Minimize pressure to comply with the researcher Show an awareness of conflicts: Patients might be uncomfortable saying no to a physician, or Having to sign the consent immediately is more uncomfortable than being able to take a copy home. Best option is for the subject to have time to decide or discuss the decision with family/friends before signing.

Recruitment Guidance Ethical Concerns Use of Protected Health Information by researchers must be minimized in their recruitment strategy. Access medical records only after the subject signs a HIPAA authorization for the research study Researchers at the time of the study application to the UCLA IRB can request an exception to HIPAA authorization for screening purposes, but it must be justified and can be denied by the IRB. Even phone or email contact with subjects by research staff to recruit subjects must be avoided prior to HIPAA authorization.

Recruitment Guidance Ethical Concerns The consent form is approved for language that removes bias and presents both benefit and risk. When the subject is approached, keep verbal explanations unbiased by avoiding language that makes the study seem excessively attractive or providing money or items as inducement to participate. Inducements given to the subject require IRB approval. Patients who are ill want to believe the study treatment will benefit them. This is called therapeutic misconception. Clinicians in particular must guard against promising benefits for a treatment under study.

Recruitment Guidance Acceptable Methods of Recruiting Research Subjects All methods may have compliance issues to both the federal Common Rule (45 CFR Part 46) or the HIPAA Privacy Rule (45 CFR Part 164) so it is necessary to discuss how subjects will be recruited within the UCLA IRB application and noted on the HIPAA Authorization Form. Methods can be divided into direct contact or indirect contact

Recruitment Guidance What is Direct contact? Clinics maintain a separate IRB approved recruitment protocol with consent asking for the person s agreement to be contacted for future research. Study investigators who are also clinicians recruit their own patients. Study investigators recruit directly people unknown to them via social networks, or public meetings. No matter the recruitment method, all recruitment documents MUST be submitted with the initial application for UCLA IRB review. If you modify the documents, it must return for re-approval.

Recruitment Guidance Then what is Indirect contact of potential subjects? Posting the study on the School of Medicine list of UCLA Clinical Trials web page and subjects can choose to use contact information if interested. Advertisements, or notices, or other media, such as television, allow subjects who are interested to contact the investigator on their own. Study investigator provides their colleagues a IRB approved Dear Patient letter giving details about the study and who to contact if interested; or provides colleagues a Dear MD letter so that the patient s physician can decide to refer his/her own patient to the study. No matter the recruitment method, all recruitment documents MUST be submitted with the initial application for UCLA IRB review. If you modify the documents, it must return for reapproval.

Recruitment Guidance Waiver of Consent/Authorization for recruitment purposes Are you identifying subjects through chart review to collect minimal amount of information to determine eligibility? Is your study a minimal risk study in which subjects will not be contacted and perhaps even de-identified? Have another reason to request a waiver? **Explain in detail why it is necessary not to consent or impossible to obtain subject consent or HIPAA authorization. UCLA IRB will review your recruitment details with the federal regulations to determine if your plan can move forward.

Recruitment Guidance-Lessons Learned Office of Inspector General for the Department of Health and Human Services released a report on recruitment practices and found two industry recruitment practices that are against the regulations: Enrollment incentives, and Breaches of patient confidentiality by using individuals listed in databases where they have not consented to being contacted **Remember that recruitment procedures need review by the IRB and there are guidelines that must be followed!!

Recruitment and Eligibility Develop screening forms to: Assist investigator with subject identification/enrollment Keep everyone on track as to all tests needed for eligibility are completed Make patient responsible for medical records when possible Obtain informed consent for any eligibility screening tests required.

Recruitment and Eligibility Tips and Tricks SOURCE DOCUMENT CHECKLIST Create a source document checklist to make this process easier AND will assist during the audit review all data that you have collected during screening the attending physician/nurse prior to registering a patient have the investigator sign and date the eligibility checklist. Answers to the eligibility checklist questions are viewed as an oath that the patient meets the criteria for entry to the study.

Recruitment and Eligibility Typically, there are NO exceptions to the eligibility criteria! National Cooperative groups will follow this rule Some industry studies will allow minor deviations but they must do the approval, the IRB must be notified, and document, document, document what is being allowed, who, and why. Save any signed informed consents from screen failures; remove any data in the database; file the eligibility criteria checklist with the consent to identify why the subject is not going to be enrolled; if your investigator wants to track screen failures, use a separate document and enter subject s initials only.

Takeaways Recruitment is a very important step in the management of a clinical trial. If you cannot recruit the numbers of people required as written in the protocol, you will not be able to analyze your hypothesis. No matter the method, all recruitment documents MUST be submitted with the initial application for UCLA IRB review. If you modify the documents, it must return for re-approval. Create an eligibility checklist that is signed by the Principal Investigator; document screening failures. Recruitment can often be thought of as easy, with lots of subjects waiting to join; but the reality is that it can be costly, timeconsuming, and will require thoughtful care to federal regulations.